LOADING
Comparing Merck & Company (MRK) and Coinbase Global (COIN) across the Health Care and Financials sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | COIN |
|---|---|---|
| Price | $124.03 | $161.44 |
| Change Today | +0.40% | +2.59% |
| Market Cap | $305.1B | $41.9B |
| P/E Ratio | 34.8 | 58.5 |
| Forward P/E | 24.4 | 117.7 |
| PEG Ratio | 6.10 | 1.53 |
| EPS | $3.55 | $2.72 |
| Revenue Growth (YoY) | 4.9% | -30.8% |
| Profit Margin | 13.6% | 12.7% |
| Return on Equity | 18.9% | 6.7% |
| Dividend Yield | 2.62% | -- |
| Beta | 0.20 | 3.35 |
| 52-Week High | $130.29 | $444.64 |
| 52-Week Low | $74.18 | $139.18 |
| Volume | 5.2M | -- |
Merck & Company is the larger company by market capitalization. Merck & Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.